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Signal peptideTwo cleavages on either side of a signal peptide separating capsid and prM on the nascent ﬂavivirus
polyprotein are uniquely regulated, such that cytosolic capsid cleavage triggers signalase cleavage of prM.
Here, we show, using two experimental approaches, that this sequential order of cleavages facilitates virus
morphogenesis: (i) A Murray Valley encephalitis virus (MVEV) variant, in which both cleavages occurred
efﬁciently and independently of each other, displayed an assembly defect. (ii) Replicon particle assembly
was assayed in packaging cells encoding the MVEV structural proteins; bicistronic expression of either
mature or membrane-anchored capsid in addition to that of the prM and E proteins showed enhanced
particle production in the latter cell line. Taken together, this study demonstrates that efﬁcient ﬂavivirus
assembly requires a cleavable transmembrane anchor of C protein and an obligatory order of cleavages at the
C–prM junction, both controlled by sequence elements in the prM signal peptide.accines Program, John Curtin
versity, P.O. Box 334, Canberra,
).
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
The positive-strand RNA genome of the ﬂaviviruses is ∼10.8 kb in
length. It is translated into a single polyprotein, which traverses the
membranes of the endoplasmic reticulum (ER) multiple times and is
proteolytically cleaved into at least 10 viral proteins: 3 structural
proteins (capsid [C], precursor to membrane [prM], and envelope [E])
and 7 nonstructural proteins (NS1 through to NS5). All cytoplasmic
cleavages of the polyprotein are catalysed by a virally encoded pro-
tease composed of the NS3 protein and its NS2B cofactor, whereas
the ER luminal cleavages are mediated by the cellular enzyme, signal
peptidase (reviewed in Lindenbach and Rice, 2001). The protease,
which cleaves the C-terminus of the NS1 protein, remains elusive.
Flaviviral gene expression from the polycistronic mRNA exploits
diverse strategies for increasing the coding capacity of the genome
and/or viral replication efﬁciency. We and others have described a
mechanism, so far unique among the ﬂaviviruses, which controls the
sequential order of two cleavages between the C and prM proteins
(Amberg et al., 1994; Amberg and Rice, 1999; Lee et al., 2000; Stocks
and Lobigs, 1998; Yamshchikov and Compans, 1993). It involves the
regulation of ER luminal signalase cleavage of prM by the viral NS2B-3
protease, which catalyses an upstream cleavage at the cytoplasmic
side of the signal peptide to generate mature C protein (Lobigs, 1993).
Thus, signalase cleavage of prM remains inefﬁcient until the cleavageof C protein has taken place (Stocks and Lobigs, 1998). Remarkably,
the signalase cleavage of prM can be induced posttranslationally by
trypsin digestion of the C protein on microsomal membranes isolated
from cells expressing uncleaved C–prM precursor (Stocks and Lobigs,
1995). Signal peptides have a three-region design, consisting of a (+)
charged N-terminal (n-region), a hydrophobic central (h-region)
and a polar C-terminal region (c-region) (von Heijne, 1990). To
uncouple the sequential order of cleavages at the C–prM junction, we
have introduced polar amino acids into the C-terminal region of the
prM signal peptide to generate a signal sequence with an “idealised”
c-region. This approach elicited efﬁcient cleavage of prM indepen-
dent of prior cleavage of C protein by the NS2B-3 protease in two
mosquito-borne ﬂavivirus models (Murray Valley encephalitis virus
[MVEV] and yellow fever virus) (Lee et al., 2000; Stocks and Lobigs,
1998) and was also successfully employed in the construction of a
self-replicating, but noninfectious, tick-borne encephalitis virus
genome containing a large truncation in the C protein (Koﬂer et al.,
2004).
Preservation of sequential proteolytic processing of C and prM
proteins is critically important for ﬂavivirus replication, given that
mutations in the c-region of the prM signal peptide, which uncoupled
cleavage coordination, were detrimental for virus growth: while
lethal in the case of yellow fever virus (Lee et al., 2000), they gave rise
to budding mutants of MVEV, which displayed greatly increased
release of nucleocapsid-free virus-like particles (VLPs) at the expense
of virion production (Lobigs and Lee, 2004). Based on these ﬁndings,
we have proposed a model for ﬂavivirus morphogenesis, which posits
that the inefﬁcient signalase cleavage of prM promotes efﬁcient
nucleocapsid incorporation into budding ﬂaviviral membranes. A
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coordinated cleavages at the C–prM junction by introduction of an
“idealised” c-region into the prM signal peptide partially prevented
cleavage of C protein. This was reﬂected in the accumulation of an
anchC precursor (the C protein linked to the prM signal peptide) in
mutant virus-infected cells (Lobigs and Lee, 2004). We hypothesised
that additional mutations in the prM signal peptide would enhance
NS2B-3 protease-catalysed cleavage of anchC and allow us to select a
variant virus, in which both cleavages at the C–prM junction take
place efﬁciently and independently of each other. Here, we identify a
combination of substitutions in the prM signal peptide, which repair
efﬁcient cleavage of anchC, while maintaining uncoupled signalase
cleavage of prM. In addition to the ﬁndings derived from the phe-
notypic characterisation of this mutant virus, we report that the
presence of a cleavable transmembrane anchor of C protein enhances
the assembly efﬁciency of MVEV replicon particles in packaging cell
lines ectopically expressing the viral structural proteins.
Results
Mutagenesis of the prM signal peptide
To generate a C–prM junction where both cleavages occur efﬁ-
ciently and independently of each other, various amino acid changes
were introduced into the prM signal peptide, in addition to the PQAQA
mutation. Four categories of mutations were tested (Fig. 1): (i) the
hydrophobicity of the n-region of the signal peptide was increased
(mutants P+E109I and P+E109I+T110V+S111L), given that
introduction of the PQAQA mutation into the yellow fever virus prM
signal peptide was lethal for virus production but selected for viable
viruses with second-site mutations involving mostly the substitution
of polar or charged amino acids in the n-region of the signal peptide
with hydrophobic residues (Lee et al., 2000); (ii) tryptophane
residues were introduced N-terminal to the c-region of the signal
peptide to prevent putative slippage of the transmembrane segment
after signalase cleavage (mutant P+T100W+S111W), given the
strong preference of tryptophane as ﬂanking residue of transmem-
brane segments for location near the lipid–water interface, thereby
stabilising the positioning of the signal peptide in the membrane
(Killian and von Heijne, 2000); (iii) the n-region of the prM signalFig. 1.Mutations introduced into the prM signal peptide. TheMVEV prM signal peptide at the
is shown at the top. Substitutions and insertions introduced into this region and designation o
are denoted by dots. The viability of infectious clone-derived mutant viruses and the corres
recorded the following day are given.peptide was lengthened by insertion of one or two uncharged polar
residues (mutants P+1aa and P+2aa); and (iv) 10 amino acids were
inserted into the n-region of the signal peptide (P+10aa) to produce
a sequence of 14 residues identical to that at the N-terminus of the
MVEV NS5 protein, which is cleaved efﬁciently from the upstream
NS4B protein by the NS2B-3 protease (Lobigs, 1992).
We have shown previously that introduction of the PQAQA
mutation into the MVEV genome is deleterious but not lethal for
MVEV replication (Lobigs and Lee, 2004). To investigate if growth of
the PQAQAmutant virus could be enhanced by the additional changes
in the prM signal peptide aimed at improving cleavage of anchC, virus
recovery following electroporation of BHK cells with full-length
RNA transcripts was compared relative to WT and PQAQA mutant.
Transfection with in vitro-synthesised rMVEV.P+E109I, rMVEV.P+
1aa, and rMVEV.P+2aa RNAs allowed recovery of virus, while the
other constructs did not produce viable virus (Fig. 1). The plaques
produced by rMVEV.P+E109I were markedly smaller than those for
variants rMVEV.P+1aa and rMVEV.P+2aa, and those for the latter
two variants were comparable in size to MVEV.PQAQA plaques but
clearly smaller than the rMVEV plaques (Fig. 1). This indicated that
the additional mutations introduced into the PQAQA prM signal
peptide were either detrimental or failed to signiﬁcantly enhance
virus growth relative to that of rMVEV.PQAQA.
In vivo selection of a PQAQA signal peptide variant with enhanced virus
growth
Variants with P+E109I, P+1aa, or P+2aa mutations showed
heterogeneous plaque sizes on Vero cells following virus ampliﬁca-
tion. Plaque isolates were sequenced in the C–prM gene region with
results shown in Table 1. Analysis of 6 isolates of rMVEV.P+E109I
showed two revertant genotypes, where, in each case, an A125V
reversion at the −1 residue of the prM signalase cleavage site was
observed. This mutation in the PQAQA motif was previously reported
to restore the coordinated cleavages at the C–prM junction (Lobigs
and Lee, 2004). Similarly, the P121L mutation in the PQAQA motif
identiﬁed in two revertants with large plaque phenotype (4–5 mm)
derived from rMVEV.P+1aa was previously found to repair the
sequential order of cleavages between C and prM proteins (Lobigs and
Lee, 2004). These revertants were not further analysed, given that theC–prM junction with cleavage sites and sequences we consider the n-, h-, and c-regions
f themutant constructs are given below. Residues, which are unchanged relative toWT,
ponding plaque sizes on Vero cell monolayers stained with neutral red on day 4 pi and
Table 1
Recovery of pseudo-reversions and compensatory mutations.
Variants (bold) and
pseudoreversions/compensatory
mutations acquireda
No. of times
isolated
Amino acid changeb
(nucleotide change)
rMVEV.P+E109I
Revertant 1 3 Ile109→Thr (ATA→ACA)
Ala125→Val (GCC→GTC)
Revertant 2 3 Ala125→Val (GCC→GTC)
rMVEV.P+1aa
Revertant 3 2 Pro121→Leu (CCA→CTA)
Variant 1 (V1) 1 Gln556→Leu (CAA→CTA)c
rMVEV.P+2aa
Variant 2 (V2) 1 Ser111→Tyr (TCC→TAC)
Glu529→Lys (GAA→AAA)d
a Infectious clone-derived variants were ampliﬁed and plaque-puriﬁed on Vero cells.
b Amino acid numbering from the ﬁrst residue in the C protein.
c Codon 264 in E protein.
d Codon 237 in E protein.
82 M. Lobigs et al. / Virology 401 (2010) 80–89aim of this investigation was to isolate a virus in which the two
cleavages at the C–prM junction are efﬁcient but take place indepen-
dently of each other.
A second rMVEV.P+1aa plaque isolate (plaque size: 2–3 mm)
showed the expected sequence at the C–prM junction, and subse-
quent sequencing of the E genes uncovered a Q556L substitution at
codon 264 in the E protein (rMVEV.P+1aa/V1; Table 1). A large
plaque variant derived from rMVEV.P+2aa showed an additional
mutation in the prM signal peptide (S111Y) and a change at residue
237 (E529K) in E protein (Table 1). Notably, the plaque size of this
variant (rMVEV.P+2aa/V2) was larger than that of WT virus (Fig. 1),
and the PQAQA motif and 2 amino acid insertion in the prM signal
peptide were intact.Fig. 2. Effect of mutations in the prM signal peptide on C protein cleavage and nucleocapsid
(MOI ∼5) or left uninfected. (A) At 18 h pi, the cells were metabolically labeled for 2 h. Imm
SDS–PAGE (15% acrylamide). Bands corresponding to C and anchC are labeled, and the posi
labeled from 18 to 24.5 h pi, the culture supernatant was clariﬁed by centrifugation, and
analysed by SDS–PAGE (15% acrylamide), and bands corresponding to the E and C proteins
was quantitated as photostimulated luminescence using the PhosphorImager scans, and valu
(5). (C) Vero cell-grown rMVEV and rMVEV.P+2aa/V2 (2×107 and 1×107 PFU, respectivel
and the E protein content in fractions collected from the top of the gradients was determinCapsid cleavage of prM signal peptide mutant viruses
Radioimmunoprecipitation with a C protein-speciﬁc antiserum
from rMVEV-infected cell lysates recovered the C protein band
(∼14.5 kDa), whereas rMVEV.PQAQA-infected cell lysates yielded
two bands of similar intensity, which correspond to C and anchC
(Fig. 2A, lanes 1 and 2, respectively) (Lobigs and Lee, 2004). In variant
rMVEV.P+2aa/V2, efﬁcient cleavage of C protein was restored, based
on recovery of only authentic C in the absence of detectable anchC
protein in the immunoprecipitation (Fig. 2A, lane 3).
To determine which of the second-site mutations in the structural
polyprotein region acquired by variant rMVEV.P+2aa/V2 accounted
for restoration of efﬁcient C cleavage, the S111Y and E529Kmutations
were introduced individually or combined into the P+2aa back-
ground. The S111Y mutation was critical for efﬁcient C protein
cleavage, while the E529K change did not enhance cleavage (Fig. 2A,
lanes 6 and 7, respectively). The presence of both pseudoreversions in
variant rMVEV.P+2aa+S111Y+E529K also resulted in an efﬁcient C
cleavage phenotype (Fig. 2A, lane 8). Variant rMVEV.P+1aa/V1 did
not display markedly improved C protein cleavage relative to rMVEV.
PQAQA (Fig. 2A, lane 9).
N-region changes in the prM signal peptide do not override efﬁcient
signalase cleavage in the presence of the PQAQA mutation
To ascertain that the mutations in the n-region of the prM signal
peptide in rMVEV+2aa/V2did not downmodulate cleavage of prMand
thereby restore dependence of the signalase cleavage on prior NS2B-3
protease-catalysed cleavage of C protein, viral protease-independent
production of prMwas evaluated in transient transfection experiments.
As shown previously (Stocks and Lobigs, 1998), transfection of COS-7
cells with a plasmid encoding the WT MVEV structural polyproteinincorporation into viral membranes. BHK cells were infected with rMVEV or variants
unoprecipitation was with an anti-C protein antiserum and proteins were subjected to
tion of a 14.3-kDa marker protein is indicated. (B) Cell monolayers were metabolically
particulate material was recovered by PEG precipitation. The secreted products were
are shown. To calculate E/C protein ratios, the radioactivity in the corresponding bands
es were divided by the number of Met and Cys residues present in E (21) and C proteins
y) were subjected, in parallel, to centrifugation on 10% to 30% sucrose density gradients,
ed using a capture ELISA.
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presence of a C–prMprecursor band in the absence of C protein cleavage
(Figs. 3A and B), while cotransfection of pSTR with a plasmid encoding
the viral NS2B-3 protease (pNS3/T) resulted in cleavage of C protein
(Fig. 3B), thereby triggering signalase cleavage of prM (Fig. 3A). In the
presence of the PQAQA mutation, signalase cleavage of prM took place
efﬁciently in the absence of the viral protease (Fig. 3A), while anchC
protein was immunoprecipitated with a C protein-speciﬁc antiserum;
anchC was not detectably cleaved to mature C protein by the NS2B/3
protease (Fig. 3B). Efﬁcient viral protease-independent cleavage of prM
due to the presence of the PQAQA mutation was not abrogated as a
consequence of additional mutations (P+2aa+S111Y) in the n-region
of the signal peptide, whichwas also reﬂected in the absence of a C–prM
precursor band (Fig. 3).
Coexpression of the viral protease in cells transfected with the
P+2aa+S111Y mutant plasmid showed evidence of partial proces-
sing of anchC to authentic C protein (Fig. 3B). However, given that a
band marginally smaller than the C protein was consistently pre-
cipitated from lysates of cells transfected with this and also the
PQAQA construct in the absence of coexpression of the NS2B-3 pro-
tease, the data were ambiguous. A discrepancy in C protein cleavage
efﬁciency in virus infected relative to transiently transfected cells has
been observed previously for the PQAQA mutant and pseudorever-
tants thereof (Lobigs and Lee, 2004), suggesting that trans-cleavage
of anchC in transfected cells is less efﬁcient than cleavage in cis
during virus infection.
Uncoupling of the coordinated cleavages at the C–prM junction results in
inefﬁcient virion assembly
Fig. 2A showed that efﬁcient anchC cleavage was restored
in rMVEV.P+2aa/V2 infected cells, while rMVEV.PQAQA andFig. 3. Effect of mutations in the prM signal peptide on prM cleavage. COS-7 cells were
transfected with WT or mutant expression plasmids encoding the MVEV structural
polyproteins in the absence (−) or presence (+) of a plasmid (pNS3/T) encoding the
NS2B-3 protease. At 2 days after transfection, the cells were metabolically labeled for
2 h, and productswere immunoprecipitated from the lysateswith an anti-E proteinmAb
(A) or a C protein-speciﬁc antiserum (B) and analysed by SDS–PAGE (12% acrylamide).
Positions of E, C–prM, and prM (coprecipitated as a result of heterodimerisation with
E) are labeled; the positions and sizes (in kilodaltons) of marker proteins are indicated.rMVEV.P+1aa/V1 displayed an inefﬁcient anchC cleavage pheno-
type. Despite this difference in anchC cleavage, each of the mutant
viruses showed markedly poorer assembly efﬁciency relative to
rMVEV based on the comparison of E relative to C protein content of
particles released from virus-infected BHK cells during a 6.5-
h metabolic labeling interval (Fig. 2B). This result was consistent
with our earlier observation for rMVEV.PQAQA showing an increased
release of VLPs at the expense of that of virion particles (Lobigs and
Lee, 2004). Flavivirus VLPs consist of prM and E protein-modiﬁed
membranes but lack a nucleocapsid (Smith et al., 1970; Stollar, 1969),
and the virion/VLP ratio of a virus preparation is a measure of
assembly efﬁciency. A marked difference in virion/VLP content in
Vero cell-grown rMVEV and rMVEV.P+2aa/V2 was observed after
sucrose gradient centrifugation (Fig. 2C), consistent with the poorer
assembly efﬁciency of the mutant virus relative to the parent.
Efﬁcient ﬂavivirus assembly requires a cleavable transmembrane anchor
of C protein
To provide direct evidence for a role of C protein cleavage by the
NS2B-3 protease in virus morphogenesis, a replicon particle assembly
assay was established, which uses ectopic expression of the MVEV
structural proteins in stably transfected cells for replicon particle
production following introduction of MVEV replicon RNA into cells.
Four packaging cell lines were generated (Fig. 4A): C–prM–E cells
inducibly express the authentic structural polyprotein region of
MVEV; C.IRES–prM–E cells express the same region, but with a termi-
nation codon after the C-terminal amino acid of C protein, followed by
an EMCV IRES for translation of the prM and E protein; in anchC.IRES–
prM–E cells, a termination codon and the IRES were inserted
downstream of anchC and the prM signal peptide for translocation
of the prM protein was duplicated; in C–pr.IRES–prM–E cells, a ter-
mination codon, the IRES and the duplicated prM signal peptide were
inserted at the furin cleavage site in prM (pr–M junction). Expression
of the predicted MVEV polypeptides shown in Fig. 4A was conﬁrmed
by pulse-labeling and radioimmunoprecipitation with C and E
protein-speciﬁc antibodies (data not shown).
To investigate packaging competence of an MVEV replicon in
the different cell lines, replicon spread was ﬁrst investigated by
ﬂow cytometry and staining with an NS1 protein-speciﬁc antibody
(Fig. 4B). While at 2 days pi with replicon particles only a minor
proportion of cells (b5%) showed NS1-speciﬁc staining, replicon
spread was clearly apparent at 4 days pi in cell monolayers expressing
the C–prM–E, C.IRES–prM–E and C–pr.IRES–prM–E polyproteins, but
not in anchC.IRES–prM–E or 293 control cells. Accordingly, the ex-
pression of anchC did not support replicon particle production, in
contrast to expression of mature C protein or the C–pr polypeptide
(which requires NS2B-3 mediated cleavage of C) in addition to the
prM and E proteins from separate coding units.
For quantitation of assembly efﬁciency in the packaging-competent
cell lines, replicon particle release wasmeasured by real-time qRT–PCR.
E protein expression from 5′cap- or IRES-driven translation was
comparable in the 3 cell lines at 4 days after induction with tetracycline
and infection with replicon particles (Fig. 4C). Replicon particle release
from C–pr.IRES–prM–E cells exceeded that from C.IRES–prM–E cells
by 23-fold at 2 days pi and ∼5-fold at later time points, demonstrating
that a cleavable membrane-anchored form of C protein markedly
improved particle production relative to expression ofmature C protein
(Fig. 4D). Replicon particle release was most efﬁcient from the
packaging cell line expressing the C–prM–E polyprotein region from a
single coding unit.
Growth of prM signal peptide variants in mammalian cells
Given the defect in virion assembly associated with mutations
introduced into the prM signal peptide that uncouple the cleavage
Fig. 4. Efﬁcient MVEV replicon packaging requires the cleavable transmembrane anchor of C protein. (A) Schematic diagram showing the MVEV polyprotein regions encoded under a
tetracycline-inducible promoter in the 293 packaging cell lines. Arrows indicate the 5′cap- and IRES-driven translation start sites. The putative membrane topology of the translation
products is indicated on right, with solid bars representing transmembrane domains and ER luminal and cytoplasmic location above and below the shaded line, respectively, and
diagonal arrows depict signal peptidase cleavages. (B) Flow cytometry histograms showing NS1 protein-speciﬁc staining in uninfected (shaded histogram) and MVEV replicon-
infected cells at 2 days pi (broken line) and at 4 days pi (solid line). The numbers indicate the percentages of NS1-positive cells. (C) Flow cytometry histograms showing E protein-
speciﬁc staining in uninduced (shaded histogram) and induced (solid line) cells at 4 days pi. (D) Real-time qRT–PCR quantitation of replicon particle-associated RNA in culture
supernatants of 293 control or packaging cell lines infected with MVEV replicon particles and induced with tetracycline over a 4-day period. Error bars indicate the SEM of two qRT–
PCR determinations for each sample shown. The data are representative of 3 independent experiments.
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mutations on virus growth was anticipated. Surprisingly, rMVEV.P+
2aa/V2 showed comparable growth relative to rMVEV in 3 mamma-
lian cell lines in terms of kinetics and plateau virus titers achieved
(Fig. 5A). In contrast, growth of rMVEV.P+1aa/V1 in Vero, K562, and
HepG2 cells was ∼10-fold poorer in comparison to WT virus butmarkedly improved in Vero cells relative to rMVEV.PQAQA (Fig. 5A).
Growth of the latter virus in K562 and HepG2 cells was not tested.
Furthermore, quantitation of virion-associated viral RNA release from
infected Vero cells by real-time qRT–PCR conﬁrmed that packaging of
viral RNA into secreted viral particles was equally efﬁcient between
rMVEV and rMVEV.P+2aa/V2 (Fig. 5B). Release of virion-associated
Fig. 5. Growth of rMVEV and prM signal peptide variants inmammalian and insect cells. (A) Vero, K562, HepG2, andmosquito C6/36 cells were infected at multiplicities of 0.02, 0.04,
0.1, and 0.2, respectively. Infectivity of the virus stocks for the different cell lines was determined by ﬂow cytometry at 18 h pi or 24 h pi in case of C6/36 cells, using a mAb speciﬁc
for NS1 protein. Virus titers in growth samples were measured by plaque assay on Vero cells (growth curves in Vero, K562, and HepG2 cells) or real-time qRT–PCR (growth curves in
C6/36 cells). Dotted lines denote detection limit of virus yield by plaque assay. (B) Real-time qRT–PCR quantitation of virion particle-associated RNA release into the culture
supernatant of infected Vero cells (MOI ∼0.5) during time intervals, as indicated. Error bars indicate the SEM of 2 qRT–PCR determinations for each sample shown.
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was reduced by 100- and 10-fold, respectively, relative to WT virus-
infected cells and consistent with the results of the growth assay.
Taken together, these data suggest that cleavage of anchC, which
is efﬁcient in rMVEV.P+2aa/V2, but incomplete in rMVEV.PQAQA-
and rMVEV.P+1aa/V1-infected cells (Fig. 3A), is critically important
for virus growth in mammalian cells. Surprisingly, the reduced
assembly efﬁciency of rMVEV+2aa/V2 relative to parent virus did
not noticeably impact on growth in mammalian cell culture.
Growth of prM signal peptide variants in mosquito cells
Mosquito C6/36 cells differed from the mammalian cell lines in
permissiveness to growth of the prM signal peptide mutants relative
to rMVEV (Fig. 5A). The more pronounced detrimental impact of the
PQAQAmutation in the prM signal peptide on MVEV growth in C6/36
in comparison to Vero cells was noted previously (Lobigs and Lee,
2004). The additional changes in the prM signal peptide in rMVEV.P+
2aa/V2 improved growth of the variant in mosquito cells but not to
the level of rMVEV, whichwas ∼10-foldmore efﬁcient than that of the
variant. The growth in C6/36 cells of rMVEV.P+1aa/V1 was not
markedly enhanced relative to that of rMVEV.PQAQA (Fig. 5A).
Only partial cleavage of anchC was found in rMVEV.P+2aa/V2-
infected C6/36 cells grown at 28 °C (Fig. 6A), in contrast to complete
cleavage seen in BHK cells (Fig. 2A). This observation could explain
the poorer growth of the variant in C6/36 cell maintained at 28 °C,
in comparison to rMVEV. However, when cultured at 37 °C, cleavage
of anchC in rMVEV.P+2aa/V2-infected C6/36 cells was markedlyenhanced (Fig. 6A), and growth of this variant was comparable to that
of rMVEV (Fig. 6B). AnchC cleavage for rMVEV.P+1aa/V1 remained
inefﬁcient in C6/36 cells grown at 37 °C as did the growth phenotype
of this variant. This result provides a further demonstration for the
critical role of anchC cleavage in virus growth.
Effect of uncoupling of the coordinated cleavages at the C–prM junction
on virus growth and virulence in mice
Virulence and pathogenesis of rMVEV.P+2aa/V2 in mice was
signiﬁcantly attenuated relative to rMVEV. While inoculation, i.p., of
102 and 103 PFU of rMVEV into 3-week-old mice was 100% lethal, as
has been shown previously (Lobigs et al., 1988), the same doses of
the mutant virus gave only 20% and 33% mortality, respectively
(P=0.001; Fig. 7A). Low-dose infection, i.v., of adult type I interferon
response defective mice, which are a highly susceptible mouse model
for ﬂaviviral encephalitis (Lee et al., 2004; Lobigs et al., 2003; Samuel
and Diamond, 2005), was 100% lethal for both viruses (Fig. 7B),
although a signiﬁcant difference in the average survival time was
observed (rMVEV: 5.2 days, rMVEV.P+2aa/V2: 7.9 days; P=0.002).
Growth of rMVEV.P+2aa/V2 in IFN-α-R−/− mice was signiﬁcantly
attenuated relative to rMVEV (Fig. 7B), given that viremia at day 2 pi
was reduced by ∼10-fold (P=0.006).
Discussion
Two cleavages at the ﬂavivirus C–prM junction take place in a
sequential order where cytosolic processing of C protein by the viral
Fig. 6. Temperature dependence of anchC cleavage in C6/36 cells and impact on
growth. (A) C6/36 cells were infected with rMVEV or variants (MOI ∼0.5) followed by
incubation at 28 °C or 37 °C for 48 h before the cells were metabolically labeled for
1.5 h. Immunoprecipitation was with an anti-C protein antiserum, and proteins were
subjected to SDS–PAGE (15% acrylamide). Bands corresponding to C and anchC are
labeled. (B) Cells were infected as above and incubated at 28 °C or 37 °C. Virus titers in
growth samples were measured by plaque assay on Vero cells.
Fig. 7. Virulence in 3-week-old BALB/c and IFN-α-receptor knockout mice. (A) Groups
of 3-week-old BALB/c mice (n=5, except group rMVEV.P+2aa/V2 [1000 PFU], where
n=6) were infected, i.p., and morbidity and mortality were recorded daily for a period
of 21 days. (B) Six-week-old IFN-α-R−/− mice were infected, i.v., with 100 PFU of
rMVEV (n=5) or rMVEV.P+2aa/V2 (n=8) and morbidity and mortality were
recorded daily. At 2 days pi, serum was collected and frozen at −70 °C. Viremia titers
were determined by plaque assay on Vero cells. Each symbol represents an individual
mouse, and mean titers are indicated by a horizontal line.
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prM protein (Amberg et al., 1994; Amberg and Rice, 1999; Lee et al.,
2000; Lobigs and Lee, 2004; Stocks and Lobigs, 1995, 1998). The prM
signal peptide is pivotal in controlling this sequential accessibility of
both cleavage sites to their respective proteases. Thus, when coor-
dination of the cleavages was uncoupled by substitutions introduced
into the c-region of the signal peptide to allow efﬁcient prM cleavage,
an anchC product with poor substrate properties for the NS2B-3
protease was generated (this study and Lobigs and Lee, 2004). Addi-
tional insertion of a dipeptide (Gly-Ser) plus selection of a compen-
satory mutation (S111Y) in the n-region of the prM signal peptide
markedly improved proteolytic processing of anchC. We did not
investigate the relative contribution of the two n-region changes on
the PQAQA mutant background to the enhanced accessibility of the
cleavage site in anchC to the viral protease. However, given that, in the
absence of the dipeptide insertion, propagation of a PQAQA variant of
MVEV selected almost exclusively for reversions in the PQAQA
mutation (Lobigs and Lee, 2004), it is likely that both n-region
changes played a role. Accordingly, by the introduction of multiple
changes into the prM signal peptide we have generated a mutant
ﬂavivirus in which signalase and NS2B-3 protease cleavages at the C–
prM junction occurred efﬁciently and independently of each other.
Phenotypic studies on this virus have provided insight into the phys-
iological role of this unique mechanism for the regulation of the
proteolytic processing events in the structural region of the ﬂavivirus
polyprotein.
We found that the cleavage of anchC was essential for the
morphogenesis of MVEV. The replicon-packaging experiments dem-
onstrated that the uncleaved form of anchC could not be utilised
for assembly and release of replicon particles. Interestingly, trans-
complementation of packaging of a yellow fever virus replicon was
achieved in anchC-expressing cells, although assembly was more
efﬁcient in cells encoding Cwith the signal peptide and a stretch of the
N-terminal amino acids of prM (Mason et al., 2006). This discrepancyfrom our results suggests virus-speciﬁc differences in accessibility
of the anchC cleavage site to the viral protease. We also found a
substantial reduction (≥10-fold) in virus growth in mammalian and
mosquito cells infected with prM signal peptide mutant viruses that
displayed partial cleavage of anchC, suggesting that either the reduced
availability of mature C protein or an inhibitory effect of the presence
of anchC on virion assembly was detrimental for virus growth. In
addition, anchC has not been observed as a by-product of ﬂavivirus
replication. Taken together, these ﬁndings are consistent with
the interpretation that efﬁcient C protein cleavage is an essential
outcome in modulation of the processing events between the C and
prM proteins.
Given the importance of efﬁcient C protein cleavage in ﬂavivirus
assembly, the question arises why this cleavage site has not evolved
such that its accessibility to the viral protease is independent of the
potentially inhibitory effect of downstream prM cleavage. The
mutational analysis in the present study conﬁrmed this possibility
and was consistent with a recent study, which showed that viral
protease-mediated cleavage of C protein was not essential for ﬂa-
vivirus replication, if liberation from the viral polyprotein was
ascertained by introduction of the autocatalytic foot-and-mouth
disease virus NS2A protein (Schrauf et al., 2009). However, in contrast
to the approaches applied by us yielding authentic C protein, that
of Schrauf et al. gave rise to a C-terminal 18-amino acid extension
of C thereby preventing distinction between the contribution of
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the C–prM junction on the deﬁcient growth phenotype of their
mutants relative to WT viruses. Previously, we have suggested that
the sequential order of cleavages at the C–prM junction enhances
nucleocapsid uptake into budding ﬂaviviral membranes (Lobigs and
Lee, 2004), an event which is apparently not driven by interactions
between the nucleocapsid and cytoplasmic domains on the viral
membrane proteins (Kuhn et al., 2002; Zhang et al., 2003). Here, we
provide proof that this is the case. Using two replicon-packaging cell
lines, which differ by the presence or absence of a cleavable trans-
membrane anchor of C protein, we show that replicon particle
formation is markedly enhanced when NS2B-3 protease-mediated
cleavage of C protein is required. It remains unclear why a cleavable,
membrane-anchored form of C protein is a preferred component for
initiation of ﬂavivirus assembly rather than the mature C protein. We
speculate that the former may be beneﬁcial for initiation of nucle-
ocapsid formation in a process putatively involving the interaction
of membrane-anchored C protein with genomic RNA and/or
oligomerisation with other C proteins. Alternatively, attraction of
the NS2B-3 protease to the budding site could play a complementary
role in virus assembly other than in the cleavage of C protein, given
that the protease may be complexed with other viral or host
components that could promote this process. Consistent with this
interpretation, it has been noted that coupling between RNA
replication and packaging is important for infectious ﬂavivirus
particle production (Khromykh et al., 2001; Liu et al., 2002; Pijlman
et al., 2006) and that the helicase domain of NS3 plays an essential
role in genome packaging and virus assembly, independently of its
enzymatic function (Patkar and Kuhn, 2008).
Others have shown that ﬂavivirus replicon particle assembly can
take place when the C and prM-E proteins are translated from
separate coding units (Gehrke et al., 2003; Khromykh et al., 1998;
Orlinger et al., 2006). However, higher replicon-packaging efﬁciencies
in trans-complementing cell lines were generally observed when the
structural proteins were expressed as a single polyprotein (Harvey
et al., 2004; Mason et al., 2006; Scholle et al., 2004). This was also
noted in the present study, which showed that MVEV replicon particle
production in 293 C–prM–E cells was optimal in comparison to
packaging cells with bicistronic expression of C and prM–E proteins.
Accordingly, at least two factors may contribute to the more efﬁcient
replicon-packaging in C–prM–E trans-complementation: (i) presence
of a cleavable transmembrane domain of C protein, as discussed
above, and (ii) retention of the viral transmembrane proteins, prM
and E, at the assembly site, which is subject to regulation by the
cleavages at the C–prM junction, and the concomitant reduction in
their secretion in the form of VLPs.
A second key ﬁnding of this study was the remarkable insensitivity
of ﬂavivirus growth in cell culture to an assembly defect involving
efﬁcient nucleocapsid uptake into budding viral membranes. Thus,
measurements of C protein incorporation into particles secreted from
virus infected cells and virion/VLP ratios showed a markedly poorer
assembly efﬁciency of variant, rMVEV.P+2aa/V2, in comparison to
WT virus. Nevertheless, growth of the two viruses in mammalian and
mosquito cells (when cultured at 37 °C to ascertain efﬁcient anchC
cleavage) was indistinguishable. This result was unexpected and
suggested that availability of the structural proteins at the site of virus
morphogenesis in mutant virus-infected cells was not rate-limiting
for infectious virion release. It is indicative of a substantial amount of
wastage of virion component during growth of ﬂaviviruses in cell
culture. Interestingly, growth and virulence of rMVEV.P+2aa/V2 in
mice was attenuated relative to rMVEV, demonstrating the greater
sensitivity of animal models to the reduced efﬁciency of virus
assembly than found in cell culture. The latter conﬁrms a physiological
relevance for the obligatory sequence of cleavages at the C–prM
junction, which may also apply to ﬂavivirus replication in the arthro-
pod vector.Materials and methods
Cells
African green monkey kidney (Vero), baby hamster kidney (BHK),
human erythroleukemia (K562), human liver carcinoma (HepG2), and
Aedes albopictus (C6/36) mosquito cells were obtained from the
American Type Culture Collection (ATCC). Vero, BHK, COS-7, and
HepG2 cells were maintained at 37 °C in minimal essential medium
(MEM;Gibco) supplementedwithnonessential aminoacids and5% fetal
bovine serum (FCS). K562 cells were maintained at 37 °C in RPMI
medium supplemented with 10% FCS, and C6/36 cells were grown at
28 °C inMEMsupplementedwithnonessential aminoacids and10%FCS.
Virus
Infectious clone-derived rMVEV was used (Lee and Lobigs, 2000).
Virus titration by plaque assay on Vero cells was performed as
described (Licon Luna et al., 2002).
Eukaryotic expression plasmids
Plasmid pSTR designates an expression plasmid (pcDNA1; Invitro-
gen) encoding MVEV cDNA for the 5′UTR, C, prM and E genes plus 11
N-terminal codons of NS1. Plasmid pPQAQA is identical to pSTR
except for substitutions in the c-region of the prM signal peptide
that introduce the PQAQA mutation, as described (Stocks and
Lobigs, 1998). Plasmid pNS3/T contains MVEV cDNA encoding 31%
NS2A through to NS5 genes with an amber termination codon at the
NS3–4A junction (Lobigs, 1992). To incorporate mutations into the
prM signal peptide, fusion PCR using pPQAQA template DNA and
appropriate oligonucleotides was performed as described (Lee and
Lobigs, 2008). Mutagenised PCR products were ligated as 521-bp
HindIII fragments into pPQAQA, replacing the corresponding WT
cDNA regions. COS-7 cell transfection with expression plasmids was
by the DEAE–dextran method (Lobigs, 1992).
Replicon-packaging cell lines
Stably transfected human embryonic kidney (293) cells for
tetracycline-inducible expression of MVEV C, prM and E genes were
constructed using the Flp-In T-Rex approach (Invitrogen) as recom-
mended by the supplier. 293 C–prM–E cells encode the MVEV
structural polyprotein region plus 11 N-terminal codons of NS1. 293
C.IRES–prM–E cells encode the same polyprotein region but with an
amber termination codon at the 3′ end of the C gene, followed by the
encephalomyocarditis virus (ECMV) IRES, which was ampliﬁed by
PCR from plasmid pKUNrep4 (Varnavski et al., 2000). This allows 5′
cap-driven translation of authentic C protein and IRES-driven
translation of the prM signal peptide (plus 3 N-terminal amino acids
[Met-Val-Arg]), prM and E. In 293 anchC.IRES–prM–E and C–pr.IRES–
prM–E cells, amber stop codons were inserted downstream of the
cDNA for the prM signal peptide or at the junction of the pr and M
genes, respectively, and followed by an IRES–prM–E gene cassette.
Ectopic protein expression was induced by the addition of tetracycline
(1 µg/ml) to the growth medium (DMEM [high glucose] supple-
mented with 10% FCS, blasticidin [15 µg/ml], and hygromycin B
[200 µg/ml]).
MVEV replicon and replicon-packaging
A plasmid (pMVEV-rep) was generated from the MVEV full-length
cDNA clone, pMVE-FL-v2 (see below), by deleting a cDNA region
encompassing most of C, prM, and E proteins from residue 28 in
C protein to residue 480 in E protein by digestion with the restriction
enzymes SpeI and MunI and religation. A serine codon (TCG) was
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directed mutagenesis to restore the correct reading frame. Replicon
particle stocks were generated by electroporation of in vitro-
transcribed replicon RNA into 293.C–prM–E cells as described (Lee
and Lobigs, 2000), and culture of the cells for 8 days when the
supernatant was harvested and stored in single-use aliquots at
−70 °C. Titers in Vero cells of the MVEV replicon particle stocks
were ∼5×106 infectious units/ml, when determined by ﬂow
cytometry performed at 24 h pi as described (Lee et al., 2006) using
the NS1 protein-speciﬁc mAb, 4G4 (Clark et al., 2007), for the
detection of replicon-infected cells. For the evaluation of replicon-
packaging efﬁciency in the different 293 packaging cell lines, cell
pellets (1.5×106 cells) were suspended in a 0.5-ml medium con-
taining replicon particles (1.5×106 Vero cell infectious units) and
incubated in a 37 °C incubator for 1 h with occasional vortexing. The
cells were washed twice and maintained in 25-cm2 cell culture ﬂasks
for up to 4 days using 5 ml of growth medium containing tetracycline
(1 µg/ml), which was replenished daily.
Genome copy quantitation by real-time RT–PCR
Virion- or replicon particle-associated genome content in culture
supernatants was measured by real-time RT–PCR. Culture super-
natants (0.1 ml) were treated with RNase (20 µg/ml for 30 min at
37 °C) and RNA-extracted using Trizol (Invitrogen). Reverse tran-
scription and real-time PCR were performed as described (Lee and
Lobigs, 2008) using the downstream primer, 5′-AACTCCAA-
GAATCTGGCTCCCA-3′, and upstream primer, 5′-GGAAATGGTGGAT-
GAGGAAAGG-3′. Each RNA sample was tested in duplicates,, and
virion RNA content was determined by extrapolation from the
standard curve generated within each experiment. Standards were
in vitro-transcribed replicon RNA generated from pMVEV-rep,
extracted with phenol–chloroform, and quantitated by spectropho-
tometry. The detection limit of the assay was 2×105 RNA copies/ml.
Full-length infectious MVEV cDNA clone
An infectious cDNA clone of MVEV has been described (Lee and
Lobigs, 2000). In this study, a second version of this clone (pMVE-FL-v2)
was used, which differed from the previous one by a silent mutation
at nucleotide 4730 (T to C change) to remove an NsiI site, plus an NsiI
site introduced at the 3′ end of the MVEV cDNA. Hence, digestion of
the clone with NsiI followed by blunt-ending with T4 DNA polymerase
and in vitro transcription with T7 RNA polymerase allowed the gen-
eration of an RNA transcript, which differed at the 3′ terminus from the
authentic MVEV RNA genome by the presence of only one additional
nucleotide.
Sucrose gradient analysis and capture ELISA
Sucrose gradient centrifugation was as described (Lobigs and Lee,
2004). Fractions of ∼0.4 ml each were collected from the top
of the gradients, diluted 2- to 5-fold in PBS, and 50 µl was loaded
onto 96-well microtiter plates coated with a rabbit anti-MVEV
hyperimmune serum diluted 1:5000 in carbonate buffer. Following
incubation for 2 h at 37 °C, plates were washed 3 times with PBS/T
(PBS containing 0.05% Tween 20) and anti-E protein mAb 8E7 (1 µg)
diluted in Blotto/Tween (5% nonfat dry milk, 0.2% Tween in PBS) was
added. The plates were incubated for 2 h at 37 °C. Following 3 washes
with PBS/T, 50 µl/well of horseradish peroxidase-conjugated goat
anti-mouse immunoglobulin diluted 1:1000 in Blotto/Tween was
added, and plates were incubated for 1 h at 37 °C. The wells were
washed 5 times with PBS/T and once with dH2O, and 50 µl/well of the
peroxidase substrate ABTS was added, and the plates were kept at
room temperature for ∼20 min to allow colour development. Plates
were read at 405 nm in a microplate reader.Metabolic labeling, immunoprecipitation, and SDS–PAGE
Transient transfections of COS-7 cells with eukaryotic expression
plasmids, metabolic labeling, and immunoprecipitations with E
protein-speciﬁc mAb, 8E7 (Hall et al., 1990), or a C protein-speciﬁc
antiserum (Lobigs and Lee, 2004) were as described (Stocks and
Lobigs, 1998), and metabolic labeling experiments using infected BHK
or C6/36 cells were performed as described (Lobigs and Lee, 2004),
with the variation of addition of the proteasome inhibitor, MG132
(Sigma), to the starvation and labeling media (10 µM ﬁnal concen-
tration) to prevent degradation of C protein. For the recovery of
virions and VLPs from the culture supernatants of infected and
metabolically labeled BHK cells, polyethylene glycol (PEG) 8000 was
used as described (Lobigs et al., 1986). The pellets were dissolved in
Laemmli sample buffer and analysed by SDS–PAGE. SDS–PAGE gels
were ﬁxed for 30 min in 10% acetic acid and rinsed with water
for 10 min, and dried gels were placed on a PhosphorImager plate for
2–3 days. The plates were scanned with a Fuji PhosphorImager.
Photoshop images shown have been minimally manipulated.
Animal experiments
Virulence assays were performed in 3-week-old BALB/c mice by
intraperitoneal (i.p.) inoculation of virus. The animals were observed
twice daily for a period of 21 days. Interferon-alpha receptor knockout
(IFN-α-R−/−) mice (Müller et al., 1994) were used at 6 weeks of age
and infected with virus intravenously (i.v.). Serum samples were
collected at 2 days pi to determine viremia levels by plaque assay on
Vero cells. Mice were euthanized when signs of encephalitis were
apparent.
Statistics
Difference in survival ratios in mouse challenge experiments was
assessed using Fischer's exact test. TheWilcoxon signed-rank test was
used to assess differences in viremia titers and average time to death
for signiﬁcance.
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